About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in Chicago | 177 Studies

Clinical Trials DepressionChicago

Depression Clinical Trials in Chicago

Find 177 clinical trials for depression near Chicago, Illinois. Connect with research centers in your area.

All Depression trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 177 trials

CompletedProgressing TAAR-1, Dopamine, and Norepinephrine in Depression Using SolriamfetolPARADIGM (Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to…NCT06360419·Little Rock, Arkansas and 39 others

Depression Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)This is a Phase 3, open-label, 1-year study of the safety, tolerability, and need for re-treatment with SAGE-217 in adult participants with MDD.NCT03864614·Dothan, Alabama and 51 others

CompletedA Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive DisorderThis is a Phase 2 clinical study evaluating the safety and effectiveness of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.NCT04479852·Phoenix, Arizona and 38 others

TerminatedProof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant DepressionThis study is looking at the efficacy, rapidity, safety, and tolerability of two doses of oral CERC-501 for treating patients with treatment resistant depression who are taking an…NCT01913535·Chicago, Illinois and 3 others

CompletedSafety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder.NCT00969150·Scottsdale, Arizona and 24 others

CompletedEfficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive DisorderThe purpose of this study is to determine the efficacy and safety of vortioxetine, once daily (QD), in adults with major depressive disorder.NCT00672620·Beverly Hills, California and 37 others

CompletedTransdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy ResponseMany patients with Major Depressive Disorder (MDD) and generalized Social Anxiety Disorder (gSAD) are treated with cognitive behavioral therapy (CBT) but few have meaningful…NCT03175068·Chicago, Illinois

CompletedEfficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive DisorderThe study will assess efficacy, safety and tolerability of 0.5 mg/day and 1 mg/day of sublingual (under the tongue) formulation of agomelatine in patients with Major Depressive…NCT01110889·Birmingham, Alabama and 47 others

CompletedAdjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant TherapyIn this Phase 4 trial we will study the safety, tolerability and efficacy of mixed salts amphetamine (MSA), trade name Adderall, augmentation of antidepressant therapy for Major…NCT02058693·Chicago, Illinois

CompletedA Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With DepressionThis study is open to adults with depression (major depressive disorder) for whom standard treatment with antidepressants alone does not work sufficiently.NCT04521478·Birmingham, Alabama and 119 others

CompletedA Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive DisorderThis six-week study will evaluate the efficacy, safety and tolerability of GSK561679 compared to placebo in female subjects with major depressive disorderNCT00733980·Cerritos, California and 17 others

CompletedEfficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDDNCT01715805·Tucson, Arizona and 84 others

CompletedAssessing Treatment Emergent Suicidal Ideation in Patients With Major DepressionThis study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during…NCT00532103·Tuscaloosa, Alabama and 14 others

CompletedA Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 StudyThis study will evaluate the efficacy and safety of ALKS 5461.NCT02158546·Little Rock, Arkansas and 57 others

CompletedA Study to Explore the Efficacy of JNJ-67953964 in the Treatment of DepressionThe purpose of this study is to evaluate the efficacy of JNJ-67953964 compared to placebo when administered as adjunctive treatment in participants with Major Depressive Disorder…NCT03559192·Tucson, Arizona and 52 others

CompletedBehavioral Activation and Varenicline for Smoking Cessation in Depressed SmokersPersons who struggle with depression smoke at high rates and experience low quit rates in treatment.NCT02378714·Chicago, Illinois and 1 other

CompletedLong-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).NCT06423781·Chandler, Arizona and 65 others

CompletedStudy to Evaluate Efficacy and Safety of Ropanicant in MDD PatientsThe primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD).NCT06836063·Little Rock, Arkansas and 34 others

TerminatedA Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and PleasureThe purpose of this study is to assess how well aticaprant works compared to placebo when given in addition to antidepressant therapy (selective serotonin reuptake inhibitor…NCT06635135·Little Rock, Arkansas and 94 others

CompletedA Clinical Trial of PRAX-114 in Participants With Major Depressive DisorderThis is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major depressive…NCT04832425·Phoenix, Arizona and 30 others

PreviousPage 3 of 9Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia